Amyloid fibril inhibition, acceleration, or fragmentation; Are nano-based approaches advance in the right direction?-Reference-Cited by-同舟云学术

Amyloid fibril inhibition, acceleration, or fragmentation; Are nano-based approaches advance in the right direction?

Published:2020-12 Issue: Volume:35 Page:100983
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Hajipour Mohammad Javad,Mohammad-Beigi Hossein,Nabipour Iraj,Mahmoudi Negar,Azhdarzadeh Morteza,Derakhshankhah Hossein,Dawud Dina El,Mohammadinejad Reza,Otzen Daniel E.

Funder

Bushehr University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference55 articles.

1. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases

2. 2012 Alzheimer's disease facts and figures Alzheimer's Association ∗

3. Toxic fibrillar oligomers of amyloid- have cross- structure

4. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

5. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micro/nanomotors for neuromodulation;Nanoscale;2024

2. Protein corona and exosomes: new challenges and prospects;Cell Communication and Signaling;2023-03-27

3. Anti-amyloid nanoclusters for the treatment of brain hazards associated with incurable neurodegenerative diseases;Materials Today Chemistry;2023-01

4. Regulation of neuroinflammation with GLP-1 receptor targeting nanostructures to alleviate Alzheimer’s symptoms in the disease models;Nano Today;2022-06

5. Light‐Driven Micromotors to Dissociate Protein Aggregates That Cause Neurodegenerative Diseases;Advanced Functional Materials;2021-09-29